Results 131 to 140 of about 77,030 (262)
Cancer Medicine, Volume 15, Issue 6, June 2026.This study investigates the potential of the gut microbiome as a non‐invasive biomarker for breast cancer (BC) using a machine learning (ML) framework. Utilizing 16S rRNA gene sequencing data from the NCBI database for 962 individuals (520 BC patients and 442 healthy controls), we processed the sequences through a FastQC, QIIME2, and DADA2 pipeline ...
Md. Tanvir Ahmed +4 more
wiley +1 more source
Metabolic Fingerprinting of Urine Reveals Metabolite Changes in Women With Breast Cancer
Cancer Medicine, Volume 15, Issue 6, June 2026.This study uses metabolomics to compare urine, plasma and serum metabolite profiles across breast cancer, benign breast disease, symptomatic and healthy controls. Significant metabolic differences—especially in amino acids—were found between BC and other groups, with moderate correlations across biofluids, suggesting potential for non‐invasive BC ...
Nur Aimi Aliah Zainurin +9 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.Histopathological analysis of the mastectomy scar during delayed autologous breast reconstruction revealed clinically occult local breast cancer recurrence. The patient subsequently underwent tumor re‐resection with preservation of the microvascular pedicle and repositioning of the DIEP flap.
David Tesina +5 more
wiley +1 more source
Beyond the Triple‐Negative Label: A Case Report on Metaplastic Breast Carcinoma
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Metaplastic breast carcinoma (MpBC) is a rare, aggressive breast malignancy with poorer prognosis than conventional subtypes. Predominant hematogenous spread, frequent triple‐negative phenotype, chemoresistance, rarity, and poorly defined treatment protocols render MpBC a significant diagnostic and therapeutic challenge for oncologists in ...
Samana Oli +8 more
wiley +1 more source
Cancer, Volume 132, Issue 11, 1 June 2026.Abstract Two new tests, a cell‐free DNA (cfDNA) blood‐based test (BBT) and multitarget stool RNA (mt‐sRNA) test with in‐laboratory fecal immunochemical testing, were recently approved by the US Food and Drug Administration, and a second BBT is under review. These tests have the potential to overcome barriers to screening.
Karli K. Kondo +4 more
wiley +1 more source
Cancer Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background This systematic review analyzes the stage at diagnosis of breast cancer and the distribution of molecular subtypes across sub‐Saharan Africa between January 2014 and December 2025. A search on Medline, African Journals Online, Web of Science, and Embase was performed.
Aïssatou Dada Fall +2 more
wiley +1 more source
Engineering Reports, Volume 8, Issue 6, June 2026.LCDLNet, a deep learning architecture, achieved 99.81% accuracy and an AUC of 0.998 for lung cancer diagnosis. This model effectively integrates multiscale features from a Custom CNN, DenseNet121, and a Transformer, leveraging Squeeze‐and‐Excitation (SE) blocks and Spatial Attention to capture complex local and global context, ensuring robust ...
Farjana Akter Chumki +2 more
wiley +1 more source
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aim Breast cancer remains a leading cause of cancer‐related mortality, and early detection through screening significantly improves survival outcomes. Given their accessibility, community pharmacists are well‐positioned to promote breast cancer screening.
Lee Siow Yen +2 more
wiley +1 more source
Determinants of mammography screening behavior in Iranian women: A population-based study
Journal of Research in Medical Sciences, 2012 Background: Breast cancer remains a substantial health concern in Iran due to delay and late stage at diagnosis and treatment. Despite the potential benefits of mammography screening for early detection of breast cancer, the performance of this screening
Mitra Moodi +3 more
doaj